Analysis of the distribution of cancers with different K-ras mutation types according to clinicopathological and lifestyle variables is summarised in Table 2: none of the clinicopathological features or lifestyle exposures tested were associated with either classification of K-ras mutation. This evidence concerns the gene KRAS and cancer.